Introduction
To date, Irritable Bowel Syndrome (IBS) remains a complex disorder to diagnose and treat. In the recent past, pharmacotherapy in conjunction with complementary and alternative medicine therapies, such as probiotics, acupuncture, and Yoga, have been recommended to better manage the primary and secondary symptoms of IBS [1, 2] . The initial randomized controlled trial reported that 12-week Remedial Yoga Module remarkably improved the symptoms in irritable bowel syndrome patients (Phase 1). RYM emphasizes tools drawn from the traditional discipline of Yoga, such as breathing, loosening the body, simple postures, regulated controlled breathing, and meditation [3] .
In Phase 2 of the study we investigated: (1) whether we could replicate the effects of RYM on the Wait-list Control group from the previous study (Phase 1) and (2) if once a week monitored Yoga session (one hour of RYM) for 12 more weeks can sustain or further enhance those improvements observed during the first 12 weeks.
Materials and methods

Participants
Wait list-Yoga group
Twenty seven patients randomized to the Wait-list Control group completed the 12 week waiting period as reported in our previous study (Phase 1). All the patients in this group were invited to participate in the RYM intervention program of three times a week for 12 weeks. They were allowed to be on their medications/ supplements for IBS symptoms during the Yoga intervention. Seven patients were able to complete the 12 week RYM intervention. After the completion, these seven patients (referred to as WL-Yoga group) were offered once a week maintenance session for 12 more weeks.
Follow-up group
A total of 28 IBS patients, 24 females and 4 males from Phase 1 volunteered for the maintenance intervention study. The sample consisted of 11 patients from the Yoga group, 10 from combination group, and 7 from WL-Yoga group. The subjects from all three groups, (those who have completed 12 weeks of RYM intervention) were combined into one group, referred to as the "Follow-up group," and were administered once a week, one hour monitored RYM sessions. The inclusion criterion for the follow-up group was the completion of 12week RYM intervention, and the only exclusion criterion was that there should not be any Yoga practice at home during the 12 week follow-up period.
Study design and procedure
Protocol of this study was approved by White Memorial Medical Center Institutional Review Board, Los Angeles, California, USA and the Institutional Ethics Committee of Swami Vivekananda Yoga University (SVYASA) Bangalore, India.
Outcomes were measured twice for the subjects in WL-Yoga group-at the end of 12 week RYM intervention and at the end of week 24 as a part of the Follow-up group. The other subjects in the Follow-up group were appraised only once, at the end of week 24. The methodology and procedures used for assessments are described in detail in our previous study (Phase 1). A brief description is given below.
Primary outcome assessments
IBS-SSS: IBS-[ 2 1 1 _ T D $ D I F F ] Symptom Severity Scale (IBS-SSS) is a self-reported visual analog scale questionnaire regarding the severity of the symptoms [4] . The score for each of the five questions ranges from 0 to 100 with a higher score indicating severity of the symptoms.
IBS-QOL: Irritable bowel syndrome quality of life (IBS-QOL) is a self-reported tool designed to assess various aspects of quality of life in IBS patients [5] . The questionnaire consists of a [ 2 1 2 _ T D $ D I F F ] five point rating of 34 items. High score reflects improved quality of life.
Secondary outcome assessments
Secondary outcome assessments were HADS, IBS-GAI, autonomic symptom score, medicine and supplement use, BMI and physical flexibility, autonomic function tests of sympathetic reactivity (hand grip and mental arithmetic tasks), and parasympathetic reactivity (measured in deep breathing and supine to upright posture). Details of these assessments are in Phase 1.
Demographic and clinical variables
Information about standard demographic and clinical variables such as age, education, employment, marital status, and years since diagnosis was reported in our previous study (Phase 1).
[ 2 1 5 _ T D $ D I F F ] 2.6. Data analyses and statistics
The analyses were carried out to evaluate two aspects of the study. The first aim was to evaluate replication of improvements in the WL-Yoga group, as previously reported in Yoga and Combination groups. Paired samples t-test was performed to analyze the pre-and post-effect of RYM intervention on WL-Yoga subjects. In Phase 1, we reported that there were no differences between Yoga and Combination groups at the end of 12 week RYM intervention. One way ANOVA tests were performed to assess if any differences existed (after intervention) in the improvements between Yoga, Combination, and WL-Yoga groups.
[ 2 2 0 _ T D $ D I F F ] The second aim was to evaluate whether the 12-week "maintenance" RYM intervention had sustained improvements (from the improvements seen in all three groups at end of 12 week RYM intervention) on a [ 2 2 2 _ T D $ D I F F ] follow-up group. All 28 patients completed the initial 12-week intervention and 12 weeks of maintenance intervention (week 24 measurements). Repeated measures ANOVA was used to analyze changes from week 0 to week 12 and week 24. This allowed us to compare changes from week 0 to week 24 [ 2 2 4 _ T D $ D I F F ] and compare maintenance or regression of improvements from week 12 to week 24. The nominal data of medicine and supplement use was analyzed using McNemar's test. All the analysis was done using SPSS (Statistical Package for the Social Sciences, IBM Corporation, NY, version 20.0) software.
Results
Post-12 week RYM intervention in Wait-list (WL-Yoga) group
The 27 patients, who comprised the Wait-list group from Phase 1 study were offered the RYM intervention. Seven patients could not attend the [ 2 2 7 _ T D $ D I F F ] Yoga intervention, due mostly to work schedule changes. A total of 20 patients were able to start the Yoga intervention. After a few weeks of Yoga intervention, 13 patients had dropped out either due to interference with their familychildren's activities (4), work-related problems [ 2 2 9 _ T D $ D I F F ] (3), finding the Yoga sessions difficult (4), or pregnancy. Fig. 1 illustrates the flow chart of patients from the start of the study through the 3 month follow-up.
Seven patients completed the 12 week RYM intervention. Even though, three RYM sessions per week [ 2 3 0 _ T D $ D I F F ] for 12 weeks were offered, subjects of the WL-Yoga group attended [ 2 3 1 _ T D $ D I F F ] an average 23 sessions (64%). Week [ 2 3 2 _ T D $ D I F F ] 12 data (before starting Yoga intervention) of the seven patients was considered as baseline data for the WL-Yoga group. Data was confirmed to be normal by Shapiro Wilke's test. Paired samples t-test revealed the efficacy of Yoga intervention on the WL-Yoga subjects. In the primary outcome assessments of IBS-SS scores (Table 1) , a 56% reduction in [ 2 3 3 _ T D $ D I F F ] severity of symptoms (p < 0.001) and a 45% improvement in the QOL (p < 0.01) was observed. The secondary outcome assessments of HADS (p < 0.01), autonomic symptom score (p < 0.01), [ 2 3 4 _ T D $ D I F F ] and IBS-GAI (p < 0.001) have all shown significant improvements with 12 weeks of RYM intervention (Table 1) . Similarly, there was a significant improvement (p < [ 2 3 7 _ T D $ D I F F ] 0.05) regarding medicine and supplement use-four patients reported reduced usage of [ 2 3 8 _ T D $ D I F F ] medication/supplements, one patient was using the same dosage, and two patients were not using any medications/supplements for the relief of IBS symptoms at baseline.
The autonomic function tests of sympathetic reactivity (handgrip and mental arithmetic tasks) showed no changes in blood pressure or [ 2 4 0 _ T D $ D I F F ] heart rate after 12 weeks of intervention. [ 2 4 1 _ T D $ D I F F ] However, a significant improvement in the handgrip strength (p < 0.01) was observed ([ 2 4 2 _ T D $ D I F F ] data not shown). In the parasympathetic tasks of deep breathing and supine to upright position (30:15), no significant changes were observed when compared to baseline values (data not shown).
We reported that after 12 weeks of RYM intervention, there were no differences between Yoga and Combination groups [ 2 4 3 _ T D $ D I F F ] and that they had both improved similarly. To assess if there were any post-intervention differences between all three groups (Yoga, Combination and WL-Yoga), the data (Yoga, n = 25; Combination, n = 26; and WL-Yoga, n = 7) was analyzed using one way ANOVA followed by post hoc analysis with Bonferroni correction. The results revealed no significant differences between groups in the primary outcome assessments of IBS-SSS and IBS-QOL ( Fig. 2a Table 1 Comparison of primary and secondary outcomes in WL-Yoga group at week 12 with week 0.
Assessments
Week 0 differences between WL-Yoga and Combination groups (Fig. 2b) .
The improvements observed with medicine and supplement use in WL-Yoga group were significantly less compared to both Yoga (p < 0.01) and Combination (p < 0.05) groups (data not shown). Table 2 depicts the characteristics of the 28 patients that volunteered for the 12 week follow up.
Follow
Per-protocol analysis.
Repeated measures ANOVA were performed for each assessment with one factor, time point (week 0, week 12 and week 24). Significant main effects and interaction between time points and assessments are given in Supplement Table 1 .
Primary outcome assessments-IBS-SSS and IBS-QOL
Post hoc analysis with Bonferroni correction of IBS-Symptom severity scale and Quality of Life score showed significant improvements at week 12 (p < 0.001) and were maintained at week 24 (p < 0.001), when compared to week 0. Furthermore, there was a significant reduction in IBS-[ 2 5 6 _ T D $ D I F F ] SSS at week 24 (28%; p < 0.01) when compared to week 12 (Fig. 3) .
A detailed analysis of the five sub-scales of IBS-SSS and eight dimensions of IBS-QOL showed no regression of improvements from week 12 to week 24. In fact, there were significant further improvements observed in two sub-scales of IBS-SSS, severity of pain (p < 0.05) and interference with life in general (p < [ 2 5 7 _ T D $ D I F F ] 0.05), and body image dimension of IBS-QOL (p < 0.01) ( Supplement Table 2a and b). There were significant improvements in all the secondary outcomes, HADS, Autonomic Symptom score, [ 2 3 4 _ T D $ D I F F ] and IBS-GAI, at week 12 and week 24 when compared to week 0 (p < 0.001). The improvements were sustained in all the secondary outcome assessments from week 12 to week 24, and in IBS-GAI, there was significant further improvement (p < 0.05) ( Fig. 4 ).
Medicine and supplement use.
At the baseline appraisal, 21 out of the 28 subjects in the Follow-up group reported medicine and supplement use and seven subjects did not use any medication/supplements. Most commonly used medication/supplements were dicyclomine, bentyl, amitiza, linzess, loperamide, psyllium, fiber drinks, herbal teas[ 2 6 0 _ T D $ D I F F ] , and probiotics. There were significant improvements in the medicine and supplement use at week 12 and week 24 (p < 0.001) when compared to week 0 (Supplement Table 3 ), and the improvements were sustained from week 12 to week 24. All 21 (34.79 AE 21.82) to week 12 (47.75 AE 28.95; p < 0.01) to week 24 (55.18 AE 34.15; p < 0.001).
Although there were no significant improvements in the diastolic blood pressure during the handgrip task, a trend of lowered diastolic blood pressure was observed. A similar trend of lowered systolic and diastolic blood pressure was observed in the mental arithmetic task. There were no changes in heart rate during this task (data not shown).
Parasympathetic reactivity tasks
There were significant improvements in the frequency domain of heart rate variability during deep-breathing task from week 0 to week 24, but not from week 0 to week 12. There was a significant reduction in LF (p < 0.001) from week 0 to week [ 2 6 7 _ T D $ D I F F ] 24, but most of the improvement was seen from week 12 to week 24. Even though HF increased significantly (p < 0.01) from week 0 to week [ 2 6 7 _ T D $ D I F F ] 24, most of the improvement (a 27% increase (p < 0.05)) was observed from week 12 to week 24 (Fig. 5 ). In the LF/HF ratio, an indicator of parasympathetic activity, there was a trend of improvement at week 12, whereas significant improvements (p < 0.01) were seen at week 24, when compared to week 0 [ 2 7 1 _ T D $ D I F F ] (data not shown).
In the second parasympathetic task of supine to upright posture (30-15 ratio), a trend of improvement was observed at week 12, [ 2 7 2 _ T D $ D I F F ] and this was significantly improved (p < 0.01) at week 24 when compared to week 0. The parasympathetic dominance in this task had improved significantly from week 12 to week 24 (p < 0.05) ( Table 3 ).
Discussion
The results reported in the present study provide encouraging evidence that the main findings of our RYM (three times a week for 12 weeks) analyses (Phase 1) are replicable (WL-Yoga group) and can be sustained during the long-term (Follow-up group) with one hour supervised RYM practices, once a week for 12 more weeks.
The clinical significance of improvements observed in the two primary outcome assessments is [ 2 7 4 _ T D $ D I F F ] substantial. At week 12, reduction in IBS-SSS was 195 points relative to week 0, which is substantially higher than the 50 point reduction [ 2 7 5 _ T D $ D I F F ] that is considered to be clinically significant improvement [4] . The consequent improvement at week 24 (follow-up) was even superior [ 2 7 6 _ T D $ D I F F ] with an improvement of 230 points. The improvements in IBS-QOL at week 12 was 26 points compared to week 0, which [ 2 7 7 _ T D $ D I F F ] is significantly higher than the 14 point gain to be considered clinically improved [6] .
The results of the WL-Yoga group after 12 weeks of RYM intervention were parallel with those of the Yoga and Combination groups in the primary outcomes of IBS-SSS and IBS-QOL and secondary outcomes of anxiety, depression, medicine and supplement use, and GAI (Phase 1). The non-significant changes observed in physical flexibility and autonomic tasks could be due to the reduced number of sessions attended by this group. These results could suggest that regular practice of RYM is essential to bring about significant changes.
The present follow-up study has shown improvements across all groups, which is in contrast to previous Yoga investigations on IBS [7] . The Global Assessment of Improvement is significantly higher than that reported in recent Yoga study (follow-up) carried out on adolescents and young adults [8] . Our results are analogous to several studies that have reported that Yoga reduces the medication usage [9] [10] [11] . Almost all the patients were able to stop using prescription/non prescription medicines and supplements for their IBS symptoms[ 2 8 3 _ T D $ D I F F ] . However, one patient reported using prescription medication at a reduced level, once every other day. Improved hip-trunk and shoulder flexibility findings of this study concur with a previous investigation [12] . The reported results of BMI in this study are in [ 2 8 5 _ T D $ D I F F ] agreement with a survey that reported long-term Yoga practitioners had reduced BMI [10] .
Similar to what was observed in the present study, a previous study reported [ 2 8 6 _ T D $ D I F F ] that a 6-month Yoga program had increased hand grip strength [13] . Our results of significant improvements in mental arithmetic task (accuracy and speed) [ 2 8 7 _ T D $ D I F F ] are concurrent with the observation by Nagendra et al. [14] . The significant changes in heart-rate and blood pressure in healthy adults reported by Indla and Narhare [15] were not replicated in the present study, which could be due to unhealthy subjects (IBS), but a trend of lowered heart rate and blood pressure was observed. Our results of parasympathetic dominance in deep breathing (frequency domain) and supine to upright posture (30:15) extend support to observations of other Yoga investigations [11, 14, 16] .
The benefits of RYM intervention enjoyed by the IBS patients in our study are far reaching. Patients self-reported that Yoga had helped in relieving other health issues that they suffered from, such as headaches, arthritis, and inflexibility. In addition, Yoga helped them regain positivity, calmness, and energy, as well as made them feel more relaxed in stressful situations. Yoga therapy reportedly helped them regain control of their lives from IBS, and they now feel that IBS has little effect on their quality of life. The patients felt completely revitalized with the Yoga therapy and planned to continue practicing Yoga regularly (Supplement Table 4 ). There were no adverse events reported in the Followup group.
The limitations of this replication and follow-up study include a high dropout rate in the WL-Yoga [ 2 9 4 _ T D $ D I F F ] and follow-up groups. This could be due to the fact that the working adult population in this study could not allocate extra time for the intervention (in addition to 12 weeks of waiting period) because of conflicts in work schedules, children's after school activities[ 2 9 5 _ T D $ D I F F ] , or other family matters. The number of Follow-up group patients (n = 28) was small compared to initial numbers of 58 that completed the first 12-week RYM intervention. This could be due to our exclusion [ 2 9 6 _ T D $ D I F F ] criterion of 'no practice of Yoga at home.' Time constraints and practicing at home were mentioned by patients for not being able to continue with the follow-up intervention. Another limitation was lack of a control group to compare the results of a weekly one-hour of RYM session.
In conclusion, our study provides [ 2 9 7 _ T D $ D I F F ] potential evidence for the continuation and replication of RYM's effects on IBS. More rigorous and longer-term trials with larger sample size are warranted to strengthen the efficacy of RYM for IBS [ 2 9 8 _ T D $ D I F F ] that was seen in the present Table 3 Comparison of supine to upright posture (30-15 ratio) in the follow-up group IBS patients at week 12 and week 24 with week 0.
Week study. With the results presented, it can be concluded that RYM alone or RYM combined with conventional care as implemented [ 2 9 9 _ T D $ D I F F ] in the present study could be a safe, efficient[ 3 0 0 _ T D $ D I F F ] , and long-term solution for IBS symptoms. A group setting with personalized attention given by the instructor could be a motivating factor for patients to adhere to such [ 3 0 1 _ T D $ D I F F ] physical activity programs.
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